Dropbox Founder Drew Houston to Step Down as CEO After 19 Years Transition to Executive Chairman CBS Ends The Late Show Era Paul McCartneys Finale Highlights Financial Decision Behind Cancellation Snowflake Q1 2027 Results Surpass Forecasts Shares Decline Tulsi Gabbard Steps Down as Trumps Intelligence Chief Amid Family Health Crisis ECB Rate Hike Push A Big Mistake as Stagflation Risks Mount Senior Economist Warns TechnologyDriven Healthcare Transformation Ushering a New Era of Medicine Perrigo Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations SRTA Q1 2026 Earnings Profit Surprise as Company Outpaces Estimates Lennar LEN Q1 2026 Earnings EPS Miss Highlights Ongoing Housing Market Headwinds Precision BioSciences DTIL Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported Stock Edges Higher WDH Q3 2025 Earnings EPS Beats Estimates by 649 Amid Steep Stock Decline Southland Holdings SLND Surges 17 as Infrastructure Play Breaks Above Key Resistance Inhibikase Therapeutics IKT Holds Near Support Amid Modest Gains Allison Transmission Holdings ALSN Holds Steady Near Resistance A Technical and Fundamental Review Agios Pharmaceuticals Holds Steady Near 28 as Trading Activity Remains Subdued MMD Shares Advance 152 Approaching Key Resistance Amid Improved Sentiment Fed Rate Hike Expectations Resurface as Inflation Data Surges Traders Price in Potential December Increase 2 Monster Stocks to Hold for the Next 10 Years LongTerm Growth Perspectives 3M India Declares 506 Per Share Dividend Final and Special Payout Announced for Shareholders Fragmented HR Systems Lead to Costly Payroll Errors for US Companies Vestas Wind Systems Shares Slip as Margins Expected at Low End of Guidance Vietnam Nears Landmark BrahMos Missile Deal with India Defense Ties Deepen The AI Economy Reshapes the American Dream Skilled Trade Workers Emerge as New Tech Beneficiaries KSPI Q4 2025 Earnings EPS Misses Estimates Modestly Shares Edge Higher Scinai Immunotherapeutics SCNI Declines 725 Eyes Key Support at 043